![\"\"](\"https:\/\/hkeemall.com\/wp-content\/uploads\/2026\/08\/1-11.jpg\")
<\/a><\/p>\nJapanese version<\/span>Tirzepatide<\/span><\/a>Detailed introduction to Tirzepatide and its weight loss effects<\/span><\/b><\/h3>\n1. Introduction to Tirzepatide<\/span><\/b><\/h3>\nTirzepatide (brand name:<\/span>Mounjaro<\/span><\/a>originally used for<\/span>Type 2 diabetes<\/span><\/a>T2DM<\/span><\/b>treatment, is also widely used for nutrition<\/span>Weight loss treatment for overweight individuals<\/span><\/b>\u3002<\/span><\/p>\n2. Status of the Japanese version of tirzepatide<\/span><\/b><\/h3>\nJapan<\/span>Ministry of Health, Labour and Welfare<\/span><\/a>(MHLW)<\/span><\/b>Approved in 2023<\/span>Mounjaro<\/span><\/b>not yet used for the treatment of type 2 diabetes, but not yet officially approved for weight loss. However, many doctors will, based on<\/span>\u300c<\/span>Indication<\/span><\/a>For external use<\/span><\/b>Off-label use of this medication to help\u2014off-label prescribing of this medication to non-diabetic patients helps with weight loss.<\/span><\/p>\nTirzepatide and other countries (such as the Japanese version of tirzepatide and other countries (such as<\/span>United States<\/span><\/a>) version is basically identical in composition, usually adopting<\/span>Subcutaneous injection<\/span><\/b>usage, dosage, starting from<\/span>Starting from 2.5mg<\/span><\/b>Start from the beginning and gradually increase to<\/span>15mg<\/span><\/b>(maximum dosage). The Japanese pharmaceutical market is strictly regulated, so patients usually need a doctor's prescription to obtain the drug.<\/span><\/p>\n3. Tirzepatide's weight loss mechanism<\/span><\/b><\/h3>\nTirzepatide's sustained efficacy helps significantly<\/span>Weight loss<\/span><\/b>primarily relies on the following<\/span>The Big Three<\/span>Mechanism of action<\/span><\/a><\/b>\uff1a<\/span><\/p>\nReduce bottlenecks, minimize bottlenecks<\/span><\/b><\/h3>\n\n- GLP-1 mechanism of action<\/span><\/b>: GLP-1 can act on the brain's<\/span>Hypothalamus beauty<\/span><\/a>Central nervous system<\/span><\/b>, enhances satiety, and reduces appetite.<\/span><\/li>\n
- GIP<\/span><\/a>Effect<\/span><\/b>: GIP can enhance<\/span>Insulin resistance<\/span><\/a><\/b>, regulate energy consumption, and further reduce<\/span>Insulin resistance<\/span><\/b>, reducing fat storage.<\/span><\/li>\n<\/ul>\n
\u2705<\/span>Result<\/span><\/b>After using tirzepatide, patients usually feel<\/span>Increased satiety<\/span><\/b>\uff0c<\/span>Decreased appetite<\/span><\/b>, especially a decreased appetite for high-sugar and high-fat foods.<\/span><\/p>\n2. Delay gastric emptying and reduce blood pressure fluctuations<\/span><\/b><\/h3>\n\n- Tirzepatide<\/span>impair gastric emptying rate<\/span><\/b>, keeping food in the stomach longer, thereby<\/span>without causing hunger<\/span><\/b>, reduce food intake.<\/span><\/li>\n
- can also help<\/span>stabilizing blood sugar binge eating<\/span><\/b>, to prevent the rapid rises and falls in blood pressure caused by<\/span>binge eating<\/span><\/b>\u6216<\/span>Hunger<\/span><\/b>\u3002<\/span><\/li>\n<\/ul>\n
\u2705<\/span>Result<\/span><\/b>Patients do not feel hungry very soon after eating.<\/span><\/b><\/p>\n3. Increase fat burning and promote lipolysis<\/span><\/b><\/h3>\n\n- GLP-1 and GIP<\/span>Merger<\/span><\/a><\/b>can promote<\/span>fat loss<\/span><\/b>, decrease<\/span>fat accumulation<\/span><\/b>, especially<\/span>Visceral fat<\/span><\/b>\u3002<\/span><\/li>\n
- Research shows that GIP can also enhance<\/span>Brown adipose tissue<\/span><\/a><\/b>activity of (BAT), increase<\/span>Energy consumption<\/span><\/b>help, help to alleviate.<\/span><\/li>\n<\/ul>\n
\u2705<\/span>Result<\/span><\/b>not only<\/span>Reduce body fat<\/span><\/b>\u4e5f<\/span>Improved diabetes blood sugar<\/span><\/b>, reduce<\/span>Type 2 diabetes risk<\/span><\/b>\u3002<\/span><\/p>\n4.<\/span>clinical research<\/span><\/a>Data (<\/span>SURMOUNT trials<\/span><\/a>\uff09<\/span><\/b><\/h3>\n\n- \n
\n- 2022<\/span>The New England Journal of Medicine<\/span><\/a><\/b>Display: A pivotal study published in (NEJM) (the SURMOUNT-1 trial) showed:<\/span>\n
Tirzepatide (brand name:<\/span>Mounjaro<\/span><\/a>originally used for<\/span>Type 2 diabetes<\/span><\/a>T2DM<\/span><\/b>treatment, is also widely used for nutrition<\/span>Weight loss treatment for overweight individuals<\/span><\/b>\u3002<\/span><\/p>\n Japan<\/span>Ministry of Health, Labour and Welfare<\/span><\/a>(MHLW)<\/span><\/b>Approved in 2023<\/span>Mounjaro<\/span><\/b>not yet used for the treatment of type 2 diabetes, but not yet officially approved for weight loss. However, many doctors will, based on<\/span>\u300c<\/span>Indication<\/span><\/a>For external use<\/span><\/b>Off-label use of this medication to help\u2014off-label prescribing of this medication to non-diabetic patients helps with weight loss.<\/span><\/p>\n Tirzepatide and other countries (such as the Japanese version of tirzepatide and other countries (such as<\/span>United States<\/span><\/a>) version is basically identical in composition, usually adopting<\/span>Subcutaneous injection<\/span><\/b>usage, dosage, starting from<\/span>Starting from 2.5mg<\/span><\/b>Start from the beginning and gradually increase to<\/span>15mg<\/span><\/b>(maximum dosage). The Japanese pharmaceutical market is strictly regulated, so patients usually need a doctor's prescription to obtain the drug.<\/span><\/p>\n Tirzepatide's sustained efficacy helps significantly<\/span>Weight loss<\/span><\/b>primarily relies on the following<\/span>The Big Three<\/span>Mechanism of action<\/span><\/a><\/b>\uff1a<\/span><\/p>\n \u2705<\/span>Result<\/span><\/b>After using tirzepatide, patients usually feel<\/span>Increased satiety<\/span><\/b>\uff0c<\/span>Decreased appetite<\/span><\/b>, especially a decreased appetite for high-sugar and high-fat foods.<\/span><\/p>\n \u2705<\/span>Result<\/span><\/b>Patients do not feel hungry very soon after eating.<\/span><\/b><\/p>\n \u2705<\/span>Result<\/span><\/b>not only<\/span>Reduce body fat<\/span><\/b>\u4e5f<\/span>Improved diabetes blood sugar<\/span><\/b>, reduce<\/span>Type 2 diabetes risk<\/span><\/b>\u3002<\/span><\/p>\n2. Status of the Japanese version of tirzepatide<\/span><\/b><\/h3>\n
3. Tirzepatide's weight loss mechanism<\/span><\/b><\/h3>\n
Reduce bottlenecks, minimize bottlenecks<\/span><\/b><\/h3>\n
\n
2. Delay gastric emptying and reduce blood pressure fluctuations<\/span><\/b><\/h3>\n
\n
3. Increase fat burning and promote lipolysis<\/span><\/b><\/h3>\n
\n
4.<\/span>clinical research<\/span><\/a>Data (<\/span>SURMOUNT trials<\/span><\/a>\uff09<\/span><\/b><\/h3>\n
\n
\n